Jonathan Marmur, MD, FACC, FRCP, Professor of Medicine, Director of Cardiac Catheterization Laboratory and Interventional Cardiology, Director of Interventional Cardiology Fellowship Program, Director of Clinical Research, Center for Cardiovascular and Muscle Research, State University of New York Health Science Center at Brooklyn, discusses the FAME trial. The results showed that for an FFR (Fractional Flow Reserve) above 75%, it was safe not to stent these blockages.

Summary
The FAME study demonstrated that for patients with a fractional flow reserve (FFR) above 75%, those that did not have stenting for coronary blockages actually did better than those patients who did receive stents.

References and Resources
www.famestudy.com
www.marmur.com
Leesar MA.Fractional flow reserve: FFR B4 U stent.Catheter Cardiovasc Interv. 2008 Aug 1;72(2):257-8.

Sponsored by The Doctor’s Channel